Despite aggressive therapy, some patients (9-22%) with Thrombotic Thrombocytopenic Purpura (TTP) do not survive. This group can be identified by monitoring LDH and platelet count during the first week of therapy. Early recognition of high patients patients could allow earlier institution of more aggressive therapy.

To read more or access our algorithms and calculators, please log in or register.